185 related articles for article (PubMed ID: 35672415)
1. Dynamic nucleosome landscape elicits a noncanonical GATA2 pioneer model.
Li T; Liu Q; Chen Z; Fang K; Huang F; Fu X; Wang Q; Jin VX
Nat Commun; 2022 Jun; 13(1):3145. PubMed ID: 35672415
[TBL] [Abstract][Full Text] [Related]
2. Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer.
Wu D; Sunkel B; Chen Z; Liu X; Ye Z; Li Q; Grenade C; Ke J; Zhang C; Chen H; Nephew KP; Huang TH; Liu Z; Jin VX; Wang Q
Nucleic Acids Res; 2014 Apr; 42(6):3607-22. PubMed ID: 24423874
[TBL] [Abstract][Full Text] [Related]
3. Androgen receptor transcriptionally regulates semaphorin 3C in a GATA2-dependent manner.
Tam KJ; Dalal K; Hsing M; Cheng CW; Khosravi S; Yenki P; Tse C; Peacock JW; Sharma A; Chiang YT; Wang Y; Cherkasov A; Rennie PS; Gleave ME; Ong CJ
Oncotarget; 2017 Feb; 8(6):9617-9633. PubMed ID: 28038451
[TBL] [Abstract][Full Text] [Related]
4. Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells.
Andreu-Vieyra C; Lai J; Berman BP; Frenkel B; Jia L; Jones PA; Coetzee GA
Mol Cell Biol; 2011 Dec; 31(23):4648-62. PubMed ID: 21969603
[TBL] [Abstract][Full Text] [Related]
5. Shaping Chromatin States in Prostate Cancer by Pioneer Transcription Factors.
Hankey W; Chen Z; Wang Q
Cancer Res; 2020 Jun; 80(12):2427-2436. PubMed ID: 32094298
[TBL] [Abstract][Full Text] [Related]
6. FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression.
Zhao JC; Fong KW; Jin HJ; Yang YA; Kim J; Yu J
Oncogene; 2016 Aug; 35(33):4335-44. PubMed ID: 26751772
[TBL] [Abstract][Full Text] [Related]
7. The essential role of GATA transcription factors in adult murine prostate.
Xiao L; Feng Q; Zhang Z; Wang F; Lydon JP; Ittmann MM; Xin L; Mitsiades N; He B
Oncotarget; 2016 Jul; 7(30):47891-47903. PubMed ID: 27374105
[TBL] [Abstract][Full Text] [Related]
8. CCAR1 promotes chromatin loading of androgen receptor (AR) transcription complex by stabilizing the association between AR and GATA2.
Seo WY; Jeong BC; Yu EJ; Kim HJ; Kim SH; Lim JE; Kwon GY; Lee HM; Kim JH
Nucleic Acids Res; 2013 Oct; 41(18):8526-36. PubMed ID: 23887938
[TBL] [Abstract][Full Text] [Related]
9. MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT.
Shen T; Wang W; Zhou W; Coleman I; Cai Q; Dong B; Ittmann MM; Creighton CJ; Bian Y; Meng Y; Rowley DR; Nelson PS; Moore DD; Yang F
J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33586682
[TBL] [Abstract][Full Text] [Related]
10. Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progression.
Shah S; Prasad S; Knudsen KE
Cancer Res; 2012 Mar; 72(5):1248-59. PubMed ID: 22258452
[TBL] [Abstract][Full Text] [Related]
11. Molecular determinants for enzalutamide-induced transcription in prostate cancer.
Yuan F; Hankey W; Wu D; Wang H; Somarelli J; Armstrong AJ; Huang J; Chen Z; Wang Q
Nucleic Acids Res; 2019 Nov; 47(19):10104-10114. PubMed ID: 31501863
[TBL] [Abstract][Full Text] [Related]
12. The Pioneering Role of GATA2 in Androgen Receptor Variant Regulation Is Controlled by Bromodomain and Extraterminal Proteins in Castrate-Resistant Prostate Cancer.
Chaytor L; Simcock M; Nakjang S; Heath R; Walker L; Robson C; Jones D; Gaughan L
Mol Cancer Res; 2019 Jun; 17(6):1264-1278. PubMed ID: 30833300
[TBL] [Abstract][Full Text] [Related]
13. The independent prognostic impact of the GATA2 pioneering factor is restricted to ERG-negative prostate cancer.
Büscheck F; Zub M; Heumann A; Hube-Magg C; Simon R; Lang DS; Höflmayer D; Neubauer E; Jacobsen F; Hinsch A; Luebke AM; Tsourlakis MC; Sauter G; Huland H; Graefen M; Haese A; Heinzer H; Schlomm T; Clauditz TS; Burandt E; Wilczak W; Steurer S; Minner S
Tumour Biol; 2019 Jul; 41(7):1010428318824815. PubMed ID: 31296150
[TBL] [Abstract][Full Text] [Related]
14. Pioneer of prostate cancer: past, present and the future of FOXA1.
Teng M; Zhou S; Cai C; Lupien M; He HH
Protein Cell; 2021 Jan; 12(1):29-38. PubMed ID: 32946061
[TBL] [Abstract][Full Text] [Related]
15. GATA2 as a potential metastasis-driving gene in prostate cancer.
Chiang YT; Wang K; Fazli L; Qi RZ; Gleave ME; Collins CC; Gout PW; Wang Y
Oncotarget; 2014 Jan; 5(2):451-61. PubMed ID: 24448395
[TBL] [Abstract][Full Text] [Related]
16. GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex.
He B; Lanz RB; Fiskus W; Geng C; Yi P; Hartig SM; Rajapakshe K; Shou J; Wei L; Shah SS; Foley C; Chew SA; Eedunuri VK; Bedoya DJ; Feng Q; Minami T; Mitsiades CS; Frolov A; Weigel NL; Hilsenbeck SG; Rosen DG; Palzkill T; Ittmann MM; Song Y; Coarfa C; O'Malley BW; Mitsiades N
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18261-6. PubMed ID: 25489091
[TBL] [Abstract][Full Text] [Related]
17. Taxane resistance in prostate cancer mediated by AR-independent GATA2 regulation of IGF2.
Plymate SR; Bhatt RS; Balk SP
Cancer Cell; 2015 Feb; 27(2):158-9. PubMed ID: 25670076
[TBL] [Abstract][Full Text] [Related]
18. MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators.
Nilsson EM; Laursen KB; Whitchurch J; McWilliam A; Ødum N; Persson JL; Heery DM; Gudas LJ; Mongan NP
Oncotarget; 2015 Nov; 6(34):35710-25. PubMed ID: 26461474
[TBL] [Abstract][Full Text] [Related]
19. The role of GATA2 in lethal prostate cancer aggressiveness.
Rodriguez-Bravo V; Carceles-Cordon M; Hoshida Y; Cordon-Cardo C; Galsky MD; Domingo-Domenech J
Nat Rev Urol; 2017 Jan; 14(1):38-48. PubMed ID: 27872477
[TBL] [Abstract][Full Text] [Related]
20. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer.
Chatterjee B
Mol Cell Biochem; 2003 Nov; 253(1-2):89-101. PubMed ID: 14619959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]